BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 10682069)

  • 1. CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer.
    Ueda A; Yuki S; Ando T; Hosokawa A; Nakada N; Kito Y; Motoo I; Ito K; Sakumura M; Nakayama Y; Ueda Y; Kajiura S; Nakashima K; Harada K; Kawamoto Y; Komatsu Y; Yasuda I
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure.
    Barreto DL; Hoekstra T; Halbesma N; Leegte M; Boeschoten EW; Dekker FW; Krediet RT;
    Perit Dial Int; 2015 Dec; 35(7):683-90. PubMed ID: 26152581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients.
    Coester AM; Zweers MM; de Waart DR; Krediet RT
    NDT Plus; 2008 Oct; 1(Suppl 4):iv41-iv45. PubMed ID: 25983985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of the peritoneal membrane.
    Struijk DG
    NDT Plus; 2008 Oct; 1(Suppl 4):iv29-iv35. PubMed ID: 25983983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysate CA125 levels after 5 years on continuous peritoneal dialysis.
    Candan C; Turhan P; Sever L; Civilibal M; Canpolat N; Caliskan S; Kasapcopur O; Arisoy N
    Pediatr Nephrol; 2011 May; 26(5):783-8. PubMed ID: 21279389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate CA125 levels in children on continuous peritoneal dialysis.
    Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N
    Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
    Krediet RT
    Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.
    Ditsawanon P; Supasyndh O; Aramwit P
    Clin Exp Nephrol; 2014 Feb; 18(1):10-5. PubMed ID: 23757048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome.
    Jiménez C; Díaz C; Selgas R; Auxiliadora Bajo M; del Peso G; Sánchez-Tomero JA; Gonzalez-Gancedo P
    Adv Perit Dial; 1999; 15():36-9. PubMed ID: 10682069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.
    Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
    Adv Perit Dial; 1997; 13():17-22. PubMed ID: 9360644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
    Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
    Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.